Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications patients willingness accept risks benefits new treatments chronic hepatitis c virus
… methods and are used to determine how your patients and other decision-makers perceive the benefits of … your treatment features and their tolerance for possible risks. Given available treatment choices, patients may be willing to accept certain risks in order to gain the benefit of …
… Willingness-to-Pay Given your product’s treatment features, do you know how much your patient’s value it? Willingness-to-pay (WTP) can be estimated using a number of …
… Benefit-Risk Assessment Do your product’s benefits outweigh its potential risks? More importantly, do you have the right data to … demonstrate this to regulators, payers, physicians, and patients? You can rely on our experienced team to help you …
… medicine in any particular controlled group. However, some patients in your study will benefit more or less than the … pipeline. Stage-by-stage, this can help you: Stage Benefits Phase I - Identify and define unique responders … labelling claims - Inform safety studies and reduce risks of adverse events Abandoned Drugs - Rescue, repurpose, …
… (QoL) assessments may be used to demonstrate additional benefits to patients and provide compelling evidence for product … to quantitatively assess the benefit/risk tradeoff of your new treatment regimen. Healthcare Resource Utilization Our …
… expectations in the US and Europe, we can help you develop new COAs and modify existing measures to support your product … use in clinical trials involving both pediatric and adult patients across a wide range of conditions. In addition, we … including regulatory submissions, reports, and publications Support to secure regulatory acceptability of …
… surveys and observational studies can help you, your patients, regulators, and prescribers understand the … in both the US and many European countries as risks and benefits, patient-centricity, and comparative … and retention Statistical analysis plans Reports and publications Data Collection and Management Depending upon …
… Research Let us help you ensure the safety of your patients by examining and understanding disease indicators … biotech, and medtech companies reduce the uncertainty of risks to patients who use their products. …
… More than ever, health economic information affects how patients, providers, payers , and regulators make decisions, … or differential responders in your data that can lead to new opportunities for your product and personalized medicine. …
… Often it is important to understand the balance that patients and other decision makers are willing to strike between treatment benefits and risks. MCDA provides quantitative information that can help …